Stock vs Stock Comparison

Illumina, Inc. vs Eli Lilly and Company

ILMN and LLY are evenly matched across key metrics.

ILMN$162.55
LLY$1064.15

🏆 Tale of the Tape

44
ILMNLLY
19.6%Profitability (Net Margin)31.7%
29.6xValuation (P/E)39.2x
18.5%Efficiency (ROIC)30.4%
7/9Health (Piotroski F)7/9
4.3Safety (Altman Z)7.8
-0.7%Growth (Rev YoY)44.7%
1.20Risk (Sharpe 1Y)0.61
1.44xBalance Sheet (D/E)3.24x
5.02%FCF Yield0.68%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.210
252-Day Correlation
0.179
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricILMNLLY
Market Cap$24.7B$985.4B
P/E Ratio29.6x39.2x
Forward P/E27.5x24.8x
P/B9.26x31.65x
Dividend Yield0.63%
Beta1.420.48

Quantitative Metrics

MetricILMNLLY
DCF Fair Value$107.79$296.11
DCF Upside-15.1%-68.2%
Piotroski F7/97/9
Altman Z4.307.84
Beneish M-2.50-1.91
FCF Yield5.02%0.68%
Net Debt/EBITDA0.0x1.1x
ROIC18.5%30.4%
WACC13.2%7.8%
ROIC – WACC5.3pp22.5pp
Gross Margin66.1%83.0%
Net Margin19.6%31.7%
Rev Growth YoY-0.7%44.7%
Sharpe (1Y)1.200.61
Max Drawdown 3Y-68.9%
FCF Payout Ratio90%

ILMN Price

Loading chart...

LLY Price

Loading chart...

ETF Exposure

ILMN found in:

ARKG4.52%
ARKK1.36%
MDYG0.67%
SPMD0.64%
MDY0.64%
MDYV0.61%
VBR0.42%
VFQY0.35%
VHT0.31%
VB0.24%
VXF0.24%
VFMO0.10%
VONV0.06%
ESGV0.04%
SPTM0.03%
VTI0.03%
VONE0.03%
ONEO0.02%
QUS0.01%

LLY found in:

XLV15.40%
IYH13.72%
VHT12.15%
VIG3.33%
SCHG3.17%
QUAL2.92%
MGK2.82%
IWF2.66%
VONG2.42%
SPYG2.36%
VUG2.31%
IVW2.23%
QUS1.95%
XPH1.90%
ESGV1.48%
DGRW1.46%
IVV1.46%
SCHX1.34%
SPY1.29%
ITOT1.29%
SCHB1.25%
VFQY1.23%
VOO1.20%
SPTM1.20%
VTI1.14%
VONE1.14%
SPLG1.10%
ARKG1.04%
URTH0.99%
ACWI0.87%
VT0.66%
VFMO0.46%
RSP0.20%
ONEO0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ILMN vs LLY: Head-to-Head Analysis

Illumina, Inc. (ILMN) and Eli Lilly and Company (LLY) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, ILMN generates a return on invested capital (ROIC) of 18.5% compared to LLY's 30.4%. This suggests LLY is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ILMN and LLY is 0.210, indicating low correlation, making them an effective diversification pair in a portfolio context.

ILMN appears in 19 ETFs tracked by SecuritiesDB, while LLY appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ILMN or LLY?

Our quantitative analysis compares ILMN and LLY across nine fundamental dimensions. ILMN and LLY are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ILMN and LLY correlated?

The 252-day correlation between ILMN and LLY is 0.210. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.